Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cancers, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

Stensgaard S., Thomsen A., Helstrup S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Communications, 2023
Plasma proteomic profiles predict individual future health risk

You J., Guo Y., Zhang Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Circulation: Genomic and Precision Medicine, 2023
Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation

Lind L., Titova O., Zeng R. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

ESC Heart Failure, 2023
Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure

de Bakker M., Loncq de Jong M., Petersen T. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Thrombosis and Haemostasis, 2023
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities

Yuan S., Xu F., Zhang H. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Scientific Reports, 2023
Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

Good E., Åkerman L., Nyström S. et al.

Olink Target 96CVDPathophysiologyPlasma

Pediatric Research, 2023
Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants

Gustafsson A., Johansson E., Henckel E. et al.

Olink Target 96Infectious DiseasesObstetricsPathophysiologyPlasma

iScience, 2023
Hospital-treated prevalent infections, the plasma proteome and incident dementia among UK older adults

Beydoun M., Beydoun H., Noren Hooten N. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Frontiers in Immunology, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

Kmezic I., Gustafsson R., Fink K. et al.

Olink Target 96NeurologyPatient StratificationPlasmaCSF

Scientific Reports, 2023
Galectin-4 is associated with diabetes and obesity in a heart failure population

Dieden A., Gudmundsson P., Korduner J. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Frontiers in Immunology, 2023
Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome

Wang T., Yang S., Long Y. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationSerum

Molecular Neurobiology, 2023
Causal Association of Cytokines and Growth Factors with Stroke and Its Subtypes: a Mendelian Randomization Study

Chen G., Lin T., Wu M. et al.

Olink Target 96CVDPathophysiologyPlasma

European Journal of Cancer, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Scientific Reports, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Mynster Kronborg T., Webel H., O’Connell M. et al.

Olink Target 96HepatologyPatient StratificationPlasma

European Journal of Heart Failure, 2023
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

Ferreira J., Packer M., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Frontiers in Endocrinology, 2023
Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome

Pascut D., Giraudi P., Banfi C. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationSerum

PLOS ONE, 2023
Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn A., Eriksson N., Assarsson E. et al.

Olink FocusCVDPathophysiologyPatient StratificationPlasma

Journal of Experimental & Clinical Cancer Research, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Wimmer K., Sachet M., Ramos C. et al.

Olink Target 96OncologyPathophysiologyPlasma

International Journal of Hygiene and Environmental Health, 2023
Joint association of air pollution exposure and inflammation-related proteins in relation to infant lung function

He S., Lundberg B., Hallberg J. et al.

Olink Target 96Respiratory DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2023
Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia

Michels E., Appelman B., de Brabander J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

3119 publications